Top of this page
Skip navigation, go straight to the content
Our Science
•
CDP323
Clinical Study Information - CDP323
| Disease area studied |
Abbreviated title | Phase | Study ID | Registry database | Study results | Lay summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Multiple Sclerosis | Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 | Phase 2 |
C32322 Terminated |
NCT00484536 2006-002204-33 |
LINK |
Polman, C. et al. Neurology;3-2-2010;74;9 Suppl. 2;A293 62nd Annual Meeting of the American Academy of Neurology (AAN), April 10-17, 2010;Toronto, Canada | |
| Multiple Sclerosis | CDP323 Biomarker Study | Phase 2 |
C32325 Completed |
NCT00726648 |
Wolf et al. PLoS ONE;2013;8;3;e58438. |